Silexion Share Price

Silexion Share Price

NASDAQ: SLXN | Micro Cap | Healthcare
$1.45
-$0.19 (-11.89%) Last updated on 19 Nov, 2026 | 02:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Corporate Actions
  • About
  • Price history
  • FAQs

Silexion Stock Performance

Open
$1.63
Prev. Close
$1.64
Circuit Range
N/A
Day Range
$1.63 - $1.63
Year Range
$0.11 - $5.02
Volume
238
Average Traded
$1.63

Silexion Share Price Today

As of 19 November 2026, Silexion Therapeutics Corp's share price is $1.45. The stock opened at $1.63, compared to its previous close of $1.64. During today's trading session, Silexion Therapeutics Corp's share price traded between $1.63 and $1.63, with an average price of $1.63. Over the past 52 weeks, the stock has recorded a high of $5.02 and a low of $0.11. In terms of performance, Silexion Therapeutics Corp's share price has declined by 70.93% over the last six months and is down 50.34% on a year-on-year basis.

Silexion Share Price Chart

Line chart of the Silexion price trend over the selected period. The price fell overall, ranging from 1.45 to 1.66, ending at 1.45.
$1.63$1.63
L
Show Current Price
H

Silexion Stock Fundamentals & Key Indicators

Market Cap
$1.92M
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Corporate Actions

Split
Ex-date: 11 Nov 2026

Split
Ex-date: 29 May 2026

Split
Ex-date: 29 Jul 2025

Split
Ex-date: 29 Nov 2024

About Silexion

Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for cancers driven by mutations in the mutations in the Kirsten rat sarcoma viral oncogene homolog (KRAS). Its proprietary technology is designed to prompt tumor cells to degrade the messenger RNA (mRNA) that bridges the oncogene and the cellular protein synthesis machinery, utilizing small interfering RNA (siRNA) constructs that are chemically modified to enhance stability and cellular uptake while maintaining biological activity that interferes with the mRNA function. Its product candidate, SIL204, is a second-generation siRNA engineered to suppress the production of mutated KRAS proteins.

Silexion Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.15
$1.63
+1,016.44%
Oct 2026
$0.25
$0.15
-46.52%
Sep 2026
$0.37
$0.27
-22.22%
Aug 2026
$1.84
$0.35
-81.13%
Jul 2026
$2.66
$1.86
-25.90%
Jun 2026
$4.89
$2.51
-49.50%
May 2026
$0.59
$4.97
+702.91%
Apr 2026
$1.25
$0.62
-49.67%
Mar 2026
$1.68
$1.23
-28.70%
Feb 2026
$1.70
$1.73
-6.25%
Jan 2026
$2.18
$1.84
-7.07%
Dec 2025
$2.75
$1.98
-31.96%

Silexion Share Price FAQs